vs
Amarin Corp plc（AMRN）与First Bancorp, Inc（FNLC）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是First Bancorp, Inc的1.7倍（$45.1M vs $25.8M），First Bancorp, Inc净利率更高（39.4% vs -23.3%，领先62.6%），First Bancorp, Inc同比增速更快（17.5% vs 7.0%），过去两年First Bancorp, Inc的营收复合增速更高（18.1% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
第一银行公司（First Bancorp, Inc）是一家银行控股公司，其核心业务通过总部位于康涅狄格州斯坦福的爱国者国家银行（Patriot Bank NA）开展，相关 banking 业务也以PNBK代码在纳斯达克挂牌交易。
AMRN vs FNLC — 直观对比
营收规模更大
AMRN
是对方的1.7倍
$25.8M
营收增速更快
FNLC
高出10.5%
7.0%
净利率更高
FNLC
高出62.6%
-23.3%
两年增速更快
FNLC
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $25.8M |
| 净利润 | $-10.5M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 48.1% |
| 净利率 | -23.3% | 39.4% |
| 营收同比 | 7.0% | 17.5% |
| 净利润同比 | 33.0% | 39.7% |
| 每股收益（稀释后） | — | $0.91 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNFNLC
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $25.8M | ||
| Q3 25 | $49.7M | $24.5M | ||
| Q2 25 | $72.7M | $22.5M | ||
| Q1 25 | $42.0M | $21.8M | ||
| Q4 24 | $62.3M | $22.0M | ||
| Q3 24 | $42.3M | $20.5M | ||
| Q2 24 | $67.5M | $19.2M |
净利润AMRNFNLC
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $10.2M | ||
| Q3 25 | $-7.7M | $9.1M | ||
| Q2 25 | $-14.1M | $8.1M | ||
| Q1 25 | $-15.7M | $7.1M | ||
| Q4 24 | $-48.6M | $7.3M | ||
| Q3 24 | $-25.1M | $7.6M | ||
| Q2 24 | $1.5M | $6.2M |
毛利率AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNFNLC
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 48.1% | ||
| Q3 25 | -22.4% | 45.2% | ||
| Q2 25 | -22.0% | 43.7% | ||
| Q1 25 | -39.9% | 39.3% | ||
| Q4 24 | -84.3% | 39.5% | ||
| Q3 24 | -59.5% | 44.6% | ||
| Q2 24 | -0.8% | 38.8% |
净利率AMRNFNLC
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 39.4% | ||
| Q3 25 | -15.6% | 37.0% | ||
| Q2 25 | -19.4% | 35.8% | ||
| Q1 25 | -37.4% | 32.5% | ||
| Q4 24 | -78.0% | 33.1% | ||
| Q3 24 | -59.4% | 36.9% | ||
| Q2 24 | 2.3% | 32.1% |
每股收益（稀释后）AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.91 | ||
| Q3 25 | $-0.02 | $0.81 | ||
| Q2 25 | $-0.03 | $0.72 | ||
| Q1 25 | $-0.04 | $0.63 | ||
| Q4 24 | $-0.12 | $0.66 | ||
| Q3 24 | $-0.06 | $0.68 | ||
| Q2 24 | $0.00 | $0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | — |
| 总债务越低越好 | — | $95.5M |
| 股东权益账面价值 | — | $283.1M |
| 总资产 | $645.8M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.34× |
8季度趋势，按日历期对齐
现金及短期投资AMRNFNLC
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
总债务AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | — | $95.5M | ||
| Q3 25 | — | $95.5M | ||
| Q2 25 | — | $95.0M | ||
| Q1 25 | — | $70.0M | ||
| Q4 24 | — | $95.0M | ||
| Q3 24 | — | $95.0M | ||
| Q2 24 | — | $70.0M |
股东权益AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $283.1M | ||
| Q3 25 | $458.9M | $274.6M | ||
| Q2 25 | $464.9M | $265.5M | ||
| Q1 25 | $473.7M | $259.7M | ||
| Q4 24 | $486.2M | $252.5M | ||
| Q3 24 | $531.4M | $256.8M | ||
| Q2 24 | $551.9M | $244.7M |
总资产AMRNFNLC
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $3.2B | ||
| Q3 25 | $659.8M | $3.2B | ||
| Q2 25 | $670.1M | $3.2B | ||
| Q1 25 | $655.7M | $3.2B | ||
| Q4 24 | $685.3M | $3.2B | ||
| Q3 24 | $750.6M | $3.1B | ||
| Q2 24 | $799.9M | $3.1B |
负债/权益比AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.36× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $37.8M |
| 自由现金流经营现金流 - 资本支出 | — | $34.6M |
| 自由现金流率自由现金流/营收 | — | 133.9% |
| 资本支出强度资本支出/营收 | — | 12.5% |
| 现金转化率经营现金流/净利润 | — | 3.72× |
| 过去12个月自由现金流最近4个季度 | — | $55.3M |
8季度趋势，按日历期对齐
经营现金流AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $37.8M | ||
| Q3 25 | $-12.7M | $12.9M | ||
| Q2 25 | $16.6M | $7.4M | ||
| Q1 25 | $-12.5M | $2.2M | ||
| Q4 24 | $-13.3M | $26.0M | ||
| Q3 24 | $-2.4M | $9.8M | ||
| Q2 24 | $-2.7M | $6.4M |
自由现金流AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | — | $34.6M | ||
| Q3 25 | — | $12.6M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $828.0K | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | — | $9.6M | ||
| Q2 24 | — | $6.3M |
自由现金流率AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | — | 133.9% | ||
| Q3 25 | — | 51.4% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 111.7% | ||
| Q3 24 | — | 47.0% | ||
| Q2 24 | — | 32.9% |
资本支出强度AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | — | 12.5% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.3% |
现金转化率AMRNFNLC
| Q1 26 | — | — | ||
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 1.42× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | -1.81× | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
FNLC
暂无分部数据
